Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

255.47 +3.09 (+1.22%)

Official Closing Price Updated: 7:00 PM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Resmed Inc (NYSE:RMD) Reports Q1 FY2026 Results: Mixed Earnings Beat Fails to Prevent Stock Decline ↗

October 30, 2025

Resmed's Q1 FY2026 earnings met expectations with $1.34B revenue and $2.55 EPS. Despite strong profit growth and margin expansion, the stock traded lower post-announcement.

Via Chartmill

Topics Earnings

ResMed (NYSE:RMD) Reports Q3 In Line With Expectations

October 30, 2025

Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above...

Via StockStory

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

October 30, 2025

From Resmed, Inc.

Via GlobeNewswire

Insights into ResMed's Upcoming Earnings ↗

October 29, 2025

Via Benzinga

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

ResMed (RMD) Reports Q3: Everything You Need To Know Ahead Of Earnings

October 28, 2025

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

ResMed Inc (NYSE:RMD) Stands Out as a Quality Investment with Strong Financials ↗

October 28, 2025

ResMed is a top-quality digital health stock with strong revenue growth, high profitability, and excellent cash flow conversion, making it a standout for long-term investors.

Via Chartmill

1 Healthcare Stock to Research Further and 2 We Ignore

October 24, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...

Via StockStory

Topics Stocks

What 9 Analyst Ratings Have To Say About ResMed ↗

October 21, 2025

Via Benzinga

SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 21, 2025

Via Benzinga

ResMed Inc. (NYSE:RMD): A Dividend Stock with Strong Profitability and Financial Health ↗

October 17, 2025

ResMed (RMD) is a reliable dividend stock with strong growth, high profitability, and a robust financial condition, ensuring sustainable payouts.

Via Chartmill

October 17, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Heylo Appoints First CEO, Poised for Revolution in Remote Disability Support

October 14, 2025

Cincinnati-based startup Heylo has announced a significant stride in its mission to revolutionize care for individuals with intellectual and developmental disabilities (I/DD) with the appointment of...

Via MarketMinute

Topics Artificial Intelligence

Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data

October 13, 2025

Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the...

Via MarketMinute

2 Cash-Heavy Stocks to Research Further and 1 We Turn Down

October 13, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Topics Electric Vehicles World Trade

2 Cash-Heavy Stocks with Solid Fundamentals and 1 We Brush Off

October 13, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

Topics Electric Vehicles World Trade

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

October 09, 2025

From Resmed, Inc.

Via GlobeNewswire

2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm

October 07, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Via StockStory

Topics World Trade

Which S&P500 stocks are gapping on Thursday? ↗

September 25, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Via Chartmill

ResMed Inc. (NYSE:RMD) Offers a Reliable Dividend with Strong Financial Health ↗

September 25, 2025

Learn how ResMed (RMD) exemplifies a strong dividend stock with a 10+ year growth streak, a low payout ratio, and robust profitability for reliable passive income.

Via Chartmill

1 Cash-Producing Stock to Target This Week and 2 We Turn Down

September 23, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

September 18, 2025

Via Benzinga

This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗

September 18, 2025

Via Benzinga

This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday ↗

September 18, 2025

Via Benzinga

1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds

September 17, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

September 16, 2025

From Resmed, Inc.

Via GlobeNewswire

Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks

September 11, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at patient monitoring stocks, starting with...

Via StockStory

Topics Artificial Intelligence

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.